LONDON, 29 March 2026 - For immediate release

Euro Biom has launched as a UK-based MHRA-licensed pharmaceutical wholesale distributor, supplying licensed medicines sourced from the UK to healthcare institutions across the GCC, Africa, Europe, CIS, and Asia. Headquartered in Harmondsworth, London - within the Heathrow logistics corridor - the company holds a Wholesale Dealer Authorisation (WDA) issued by the Medicines and Healthcare products Regulatory Agency (MHRA) and operates in full compliance with Good Distribution Practice (GDP) guidelines.

The company exports to hospitals, government health ministries, NGOs, and private healthcare groups across more than 40 countries, with a particular focus on markets in the Gulf Cooperation Council and Sub-Saharan Africa where access to reliable, compliant UK-sourced pharmaceutical supply has historically been limited.

Specialist Supply Capability

Euro Biom has built its operations around the complex end of pharmaceutical supply - shortage situations, unlicensed and named patient medicines, urgent institutional procurement, and specialist products that conventional wholesale channels do not routinely handle. All shipments are supported by full chain of custody documentation and batch traceability from source to destination.

Compliance documents including WDA certificates and GDP records are available on request for supplier due diligence by healthcare institutions, government procurement bodies, and international NGOs.

"Access to quality medicines should not be determined by geography. Our MHRA authorisation and proximity to Heathrow allow us to connect the UK pharmaceutical supply chain with healthcare buyers in markets where reliable, compliant supply is most needed."

- Shikhar Bhatt, Head of Operations, Euro Biom

Serving GCC and African Healthcare Markets

The GCC and African healthcare markets represent a significant and growing demand for UK-sourced medicines. NHS-grade pharmaceutical supply, MHRA-licensed provenance, and full GDP-compliant cold chain logistics are increasingly required by hospital procurement teams and health ministry buyers in these regions - particularly for oncology, HIV, cardiovascular, and critical care medicines.

Euro Biom's location within the Heathrow corridor provides direct access to international freight infrastructure, enabling fast turnaround on urgent orders and efficient cold chain management for temperature-sensitive products across all major export routes.

Regulatory Standing

Euro Biom operates under the following regulatory framework:

  • MHRA Wholesale Dealer Authorisation (WDA) - UK-issued, current
  • Good Distribution Practice (GDP) - full compliance
  • Named patient and unlicensed medicine supply under MHRA-authorised frameworks
  • Full chain of custody documentation for every shipment
  • Batch traceability from manufacturer to end destination

For verified healthcare institutions: Supplier due diligence documentation including WDA certificates and GDP records is available on request. Contact work@eurobiom.co.uk or submit an enquiry via the website.

Also Published On

This press release has been distributed on the following newswire platforms: OpenPR and PRLog.

About Euro Biom

Euro Biom Ltd is an MHRA-licensed pharmaceutical wholesale distributor based in Harmondsworth, London. The company holds a Wholesale Dealer Authorisation and exports licensed medicines sourced from the UK to hospitals, health ministries, NGOs and private healthcare institutions across the GCC, Africa, Europe, CIS and Asia. Euro Biom specialises in unlicensed and named patient medicines, shortage supply, and complex institutional procurement. Company No. 15380737. Registered in England and Wales.

Submit a Product Enquiry

We supply verified healthcare institutions globally. Tell us what you need and our team will respond within one business day.

Contact Our Team